{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:29:15Z","timestamp":1794324555801,"version":"4.9.0"},"reference-count":0,"publisher":"ScopeMed","issue":"2","license":[{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/www.medarch.org\/?sec=licenseinfo"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Arch"],"published-print":{"date-parts":[[2024]]},"abstract":"<jats:p>Background: The early establishment of prophylaxis and immediate administration of anticoagulant therapy upon the diagnosis of venous thromboembolism should be the treatment objectives in these patients. Objective: The study aimed to determine the optimal cut-off point of Calprotectin, IL-6 (interleukin-6), CRP (C reactive protein) to differentiate UC, IBS-D. Methods: A cross-sectional descriptive study of 335 individuals \u226515 years old was performed, including 31 healthy controls, 215 with IBS-D, 71 diagnosed with UC, and 18 diagnosed with CD. Receiver Operating Characteristics (ROC), sensitivity, specificity, and area under curve (AUC) were computed. Results: The results showed that the median value of calprotectin (IQR) in healthy participants was 20.0 (6.0 - 34.0) \u00b5g\/g; 17,7 (8,7-38,9) \u00b5g\/g in IBS-D group; 1710.0 (588 - 4260,0) \u00b5g\/g in UC group; and 560.5 (177.8 - 1210.0) \u00b5g\/g in CD group. Calprotectin concentration in IBD group including UC and CD was higher than IBS-D with p&lt;0.05. The median value of CRP (range IQR) was 1,3 (0,9 \u2013 2,3) mg\/L in IBS-D group; 7.0 (2.4 -16.6) mg\/L in UC group; and 10.1 (2.2 - 42.5) mg\/L in CD group. CRP concentration in IBD group including UC and CD was higher than IBS-D with p&lt;0.05. The median value of IL-6 (range IQR) was 2.3 (1.6 \u2013 5.7) pg\/mL in IBS-D group; 16.8 (9.4 -  47.0) pg\/mL in UC group; and 9.4 (7.9 - 11.0) pg\/mL in CD group. Calprotectin concentration in IBD group including UC and CD was higher than IBS-D with p&lt;0.05. The optimal cut-off point of calprotectin that differentiated IBS-D from IBD was 110.5 \u00b5g\/g, with sensitivity and specificity of 93.3% and 91.4%, respectively; of IL-6 was 7.2 pg\/mL with sensitivity and specificity of 92.0% and 78.0%, respectively; of CRP of 2.4 mg\/L had specific sensitivities of 83.3% and 86.0%, respectively. Conclusion: The Calprotectin immunoassay has the best value in discriminating between IBD and IBS-D.<\/jats:p>","DOI":"10.5455\/medarh.2024.78.105-111","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T11:55:26Z","timestamp":1710762926000},"page":"105","source":"Crossref","is-referenced-by-count":5,"title":["Role of Calprotectin, IL-6, and CRP in Distinguishing Between Inflammatory Bowel Disease and Diarrhea Predominant Irritable Bowel Syndrome"],"prefix":"10.5455","volume":"78","author":[{"given":"Bui","family":"Huong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No author","family":"No author","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen","family":"Hien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen","family":"Dung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao","family":"Quang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen","family":"Vinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Phuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen","family":"Nhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3407","container-title":["Medical Archives"],"original-title":[],"link":[{"URL":"https:\/\/ejmanager.com\/mnstemps\/10\/10-1710764519.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:57:20Z","timestamp":1791482240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ejmanager.com\/mnstemps\/10\/10-1710764519.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5455\/medarh.2024.78.105-111","relation":{},"ISSN":["0350-199X"],"issn-type":[{"value":"0350-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}